Investments in speculative biotech can cover lots of ground in the healthcare arena. From looking for a cure to cancer, all the way to weight management, there is a never ending supply of companies attempting to change the world of healthcare. Most are risky investments at best as these companies navigate through the maze or FDA regulations and clinical trials, while trying to keep their heads above water financially. This is where we find one special company named Advanced Cell Technology (OTCQB:ACTC).
At first glance it does not seem to have much investment potential. With a current market capitalization of only $180 million, ACTC is definitely not an investment for the timid. That being the case, there are...
Only subscribers can access this article, which is part of the PRO research library covering 3,741 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: